NEW NOBEL PRIZE SCIENCE BASED NOXO SLEEP EASY INTRODUCED BY OLFACTORY BIOSCIENCES CORP
June 29, 2010 (PRLEAP.COM) Health News
Wynnewood, PA -– TUESDAY, JUNE 29, 2010 — Olfactory Biosciences Corp., (OTC Pink Sheets: OLFC) announced today that it has introduced a new and effective and affordable sleep product, NOXO Sleep Easy™. The company produces NOXO Wellness products and is the leading producer of non-invasive Behavioral Modification products and Wellness products that provide relief to common health problems such as smoking cessation or weight control, as examples. www.noxoinfo.comNOXO Sleep Easy™ is the natural and effective way to have a full and pleasant night's sleep, Many of our customers prefer using NOXO Sleep Easy™to replace using popular and dangerous medications such as Ambien which Yahoo Answers say are " similar to drugs in the benzodiazepine family, such as Xanax, Valium and Klonopin. Ambien is not indicated for long term use, as it can theoretically cause habituation. Use it only on an as-needed basis and do not mix it with alcohol or other sedatives". www.noxoinfo.com/sleep
There are no side effects with NOXO Sleep Easy™ and since it's made with 100% natural ingredients, there is no danger of memory loss or other untoward effects the prescription sleep products have nor is there any problem stopping its use at any time and will save you money.
The company has taken NOBEL Prize science related to discoveries of odorant receptors in the nose and the organization of the olfactory system, and has developed unique NOXO Wellness Products that are affordable and made from all natural ingredients.
NOXO products are proprietary formulations of unique all natural ingredients, which are soy-based, absorbed into the skin and not visible after application. Products are based on olfactory perception altering technology.
They include NOXO Autism Alleviation™, NOXO ADD Relief™, NOXO Sleep Easy™, NOXO Odor Defense™, NOXO QuiteSmoking™, NOXO Appetite Control™, NOXO Sweets Control™, NOXO Memory Enhancer™, NOXO Study Boost™, NOXO Menopause Relief™, NOXO Mood Boost™, NOXO Nausea Relief™, NOXO Stress Relief™, and NOXO Anxiety Relief™ www.noxoinfo.com
ABOUT US
Olfactory Biosciences Corp.'s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common health problems such as smoking cessation or weight control, as examples. The company has taken NOBEL Prize science related to discoveries of odorant receptors in the nose and the organization of the olfactory system, and has developed unique wellness products that are affordable and made from all natural ingredients.
Olfactory Biosciences Corp. offers the most advanced and innovative wellness products with the potential to change the way we approach wellness issues today. Olfactory Biosciences Corp's unique advantages will make NOXO products the most sought-after wellness products in the alternative medicine market, creating a growth rate ten times higher than most in the this growing category.
Consumers concerned about their health are looking for alternatives to replace conventional, over-the-counter consumer medical products. We provide natural wellness products that are both effective and affordable.
Those interested in the NOXO Authorized Dealership, please consider NOXO's products to feature as part of your retail store, catalogue or service. Our headquarters are located in Pennsylvania where seasoned teams of business professionals develop winning strategies for products in the health and wellness industry. We are the exclusive manufacturer and/or wholesale distributor for these unique and effective products for modifying behavior. Please complete our online application form at: www.noxoinfo.com and click the bottom right arrow that says "Become a Dealer".
Investor & Media Relations:
Tel: 951-657-8840
email: info@wsmg.biz
Safe Harbor for Public Companies
Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders. Olfactory Biosciences Corp., "The Company" currently does not file periodic filings with the Securities and Exchange Commission but will publish financials on the Olfactory Biosciences Corp. website as they become available.
Richard Stevenson
Olfactory Biosciences Corp., Inc
333 E. Lancaster Ave.
Suite 317
Wynnewood, PA 19096
USA
Phone: 484-278-1626